Home » Topics » BioWorld Science

BioWorld Science
RSS

BETR-001 shows antidepressant activity in preclinical models

April 7, 2022

FDA clears IND for BiOneCure's anti-Trop-2 ADC, BIO-106

April 7, 2022

Novel series of glucosylceramide synthase inhibitors presented for treating Parkinson's disease

April 7, 2022

NPC1L1 gene polymorphisms tied to coronary artery calcification

April 7, 2022

ACE2-independent blood cell infection linked to severe COVID

April 6, 2022

N-LIfT results in complete cell killing in solid tumor organoids

April 6, 2022

NOX2 inhibition reverses obesity-induced atrial fibrillation

April 6, 2022

Can-Fite developing topical formulation of piclidenoson for the treatment of psoriasis

April 6, 2022

Atreca announces agreement with Zymeworks and selection of new clinical candidate

April 6, 2022

PEAR1 genetic variation tied to big endothelin levels in patients with acute myocardial infarction

April 6, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...